The Combretastatins, discovered by ASU researchers, are a series of very potent antineoplastic compounds. Combretastatin A-4 (CA4), the most potent compound of the family, is currently undergoing phase III human cancer clinical trials. ASU researchers have conducted extended SAR on Combretastatins. They eventually synthesized structural analogs...